[S,S]-Reboxetine

TERMINATED · PHASE2 · Pain

The study was stopped due to business/operational issues.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.